Eli Lilly and Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Eli Lilly and Company (Eli Lilly or 'the company') is a pharmaceutical company that develops, discovers, manufactures, and sells pharmaceutical products. The company offers pharmaceutical products in the therapeutic areas of neuroscience, endocrinology, oncology, cardiovascular, and immunology. The company offers its products under the brands including Baqsimi, Basaglar, Cymbalta, Olumiant,Verzenio, cialis and Erbitux. The company distributes its products through wholesalers, on-line health care channels and sales representatives. Eli Lilly offers its products to pharmacies, hospitals, physicians, and other health care professionals. It has business presence in the US, Japan, Europe, and other countries. The company is headquartered in Indianapolis, Indiana, the US.Scope
- Detailed information on Eli Lilly and Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eli Lilly and Company in the form of a SWOT analysis
- An in-depth view of the business model of Eli Lilly and Company including a breakdown and examination of key business segments
- Intelligence on Eli Lilly and Company's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eli Lilly and Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Eli Lilly and Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Eli Lilly and Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Eli Lilly and Company's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Eli Lilly and Company: Company Overview
- Eli Lilly and Company: Overview and Key Facts
- Eli Lilly and Company: Overview
- Eli Lilly and Company: Key Facts
- Eli Lilly and Company: Key Employees
- Eli Lilly and Company: Key Employee Biographies
- Eli Lilly and Company: Major Products and Services
- Eli Lilly and Company: Management Statement
- Eli Lilly and Company: Locations and Subsidiaries
- Eli Lilly and Company: Key Competitors
- Eli Lilly and Company: Company Analysis
- Eli Lilly and Company: Business Description
- Eli Lilly and Company: SWOT Analysis
- Eli Lilly and Company: SWOT Overview
- Eli Lilly and Company: Strengths
- Eli Lilly and Company: Weaknesses
- Eli Lilly and Company: Opportunities
- Eli Lilly and Company: Threats
- Eli Lilly and Company: Corporate Financial Deals Activity
- Eli Lilly and Company: Financial Deals Overview
- Eli Lilly and Company: Targets and Partners
- Eli Lilly and Company: Top Deals 2019 - 2023YTD*
- Eli Lilly and Company: Advisors
- Eli Lilly and Company: Top Legal Advisors
- Eli Lilly and Company: Top Financial Advisors
- Eli Lilly and Company: Mergers and Acquisitions
- Eli Lilly and Company: Corporate Venturing
- Eli Lilly and Company: Capital Raising
- Eli Lilly and Company: Partnership
- Eli Lilly and Company: Divestments
- Eli Lilly and Company: Recent Developments
- Eli Lilly and Company: News and Events Summary
- Eli Lilly and Company: Business Expansion
- Eli Lilly and Company: Contracts
- Eli Lilly and Company: Financial Performance
- Eli Lilly and Company: Market Developments
- Eli Lilly and Company: Regulatory and Legal Events
- Eli Lilly and Company: Research & Development
- Appendix
- Contact Us
- Methodology
Table 1: Eli Lilly and Company: Key Facts
Table 2: Eli Lilly and Company: Key Employees
Table 3: Eli Lilly and Company: Locations and Subsidiaries
Table 4: Eli Lilly and Company: Key Competitors
Table 5: Eli Lilly and Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Eli Lilly and Company: M&A Activity by Geography (TTM*)
Table 7: Eli Lilly and Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Eli Lilly and Company: M&A Average Deal Size - Value (US$m)
Table 9: Eli Lilly and Company: Targets and Partners
Table 10: Eli Lilly and Company: Top Deals 2019 - 2023YTD*
Table 11: Eli Lilly and Company: Legal Advisor Ranking by Value (US$m)
Table 12: Eli Lilly and Company: Financial Advisor Ranking by Value (US$m)
Table 13: Eli Lilly and Company: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Eli Lilly and Company: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Eli Lilly and Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Eli Lilly and Company: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Eli Lilly and Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Eli Lilly and Company: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Eli Lilly and Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Eli Lilly and Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Eli Lilly and Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Eli Lilly and Company: Divestments by Geography (2019 - YTD*2023)
Table 23: Eli Lilly and Company: News and Events Summary
Table 24: Eli Lilly and Company: Business Expansion
Table 25: Eli Lilly and Company: Contracts
Table 26: Eli Lilly and Company: Financial Performance
Table 27: Eli Lilly and Company: Market Developments
Table 28: Eli Lilly and Company: Regulatory and Legal Events
Table 29: Eli Lilly and Company: Research & Development
List of Figures
Figure 1: Eli Lilly and Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Eli Lilly and Company: M&A Activity by Geography (TTM*)
Figure 3: Eli Lilly and Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Eli Lilly and Company: M&A Average Deal Size - Value (US$m)
Figure 5: Eli Lilly and Company: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Eli Lilly and Company: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Eli Lilly and Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Eli Lilly and Company: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Eli Lilly and Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Eli Lilly and Company: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Eli Lilly and Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Eli Lilly and Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Eli Lilly and Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Eli Lilly and Company: Divestments by Geography (2019 - YTD*2023)
